CFS Investment Advisory Services’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.53M Sell
11,660
-545
-4% -$71.8K 0.1% 158
2026
Q1
$1.68M Buy
12,205
+601
+5% +$84.2K 0.12% 142
2025
Q4
$1.42M Buy
11,604
+163
+1% +$19.8K 0.1% 147
2025
Q3
$1.38M Buy
11,441
+348
+3% +$39.6K 0.1% 153
2025
Q2
$1.23M Buy
11,093
+86
+0.8% +$9.15K 0.1% 152
2025
Q1
$1.23M Sell
11,007
-140
-1% -$14.4K 0.11% 150
2024
Q4
$1.03M Sell
11,147
-36
-0.3% -$3.24K 0.09% 155
2024
Q3
$938K Buy
11,183
+210
+2% +$16K 0.08% 158
2024
Q2
$753K Buy
+10,973
New +$732K 0.06% 163
2023
Q3
Sell
-6,727
Closed -$518K 185
2023
Q2
$518K Buy
+6,727
New +$537K 0.07% 159

Other funds holding GILD

CFS Investment Advisory Services's GILD Position: Q2 2026 in Review

CFS Investment Advisory Services reduced its Gilead Sciences (GILD) stake by 4.5% in Q2 2026, selling an estimated $71.8K and leaving 11,660 shares worth $1.53M. The position accounts for 0.1% of the portfolio, ranked #158.

CFS Investment Advisory Services first reported a position in GILD in Q2 2023 and has held it in 10 quarters since. The position peaked at $1.68M in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • CFS Investment Advisory Services held 11,660 shares of Gilead Sciences worth $1.53M as of Q2 2026.
  • CFS Investment Advisory Services sold 545 Gilead Sciences shares in Q2 2026, an estimated $71.8K.
  • Gilead Sciences made up 0.1% of CFS Investment Advisory Services's portfolio in Q2 2026, its #158 holding.
  • CFS Investment Advisory Services first reported a position in Gilead Sciences in Q2 2023 and has held it in 10 quarters since.
  • CFS Investment Advisory Services's Gilead Sciences position peaked at $1.68M in Q1 2026.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on CFS Investment Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.